Results 191 to 200 of about 334,561 (215)

Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib. [PDF]

J Int Med Res
Wu Y, Zhao Y, Yu L, Wang R, Feng W, Wu Y, Wang L, Chen H, He Z, Wang Q.   +9 more
europepmc   +1 more source

ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors. [PDF]

Cancers (Basel)
Kimura R, Adachi Y, Hirade K, Kisoda S, Yanase S, Shibata N, Ishii M, Fujiwara Y, Yamaguchi R, Fujita Y, Hosoda W, Ebi H.   +11 more
europepmc   +1 more source

RON receptor tyrosine kinase regulates glycolysis through MAPK/CREB signaling to affect ferroptosis and chemotherapy sensitivity of thyroid cancer cells. [PDF]

Mol Med Rep
Jin X, Zhu H, Chen X, Yang Y, Song D.
europepmc   +1 more source

Skin Toxicities Induced by Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and their Influence on Treatment Adjustments in Lung Cancer Patients. [PDF]

Acta Derm Venereol
Lee JS, Woo J, Kim TM, Kim N, Keam B, Jo SJ.   +5 more
europepmc   +1 more source

Affinity purification mass spectrometry characterization of the interactome of receptor tyrosine kinase proline rich motifs in cancer

Jones CM, Rohwedder A, Suen KM, Mohajerani SZ, Calabrese AN, Knipp S, Bedford MT, Ladbury JE.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly